Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 570 participants.

Also called NCT01373632

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 570 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01373632
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01373632. Randomized; no masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2012-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Firebird 2 Versus Excel Sirolimus-eluting Stent in Treating Real-world Patients With Coronary Artery Disease
Acronym
FESTA
Intervention (Device)
Firebird 2 sirolimus-eluting stent
Intervention (Device)
Excel sirolimus-eluting stent
Lead sponsor
Shanghai Jiao Tong University School of Medicine (class: other)

Record details

Record id
cardio:ct-nct01373632
Content hash
b37f7d5328634af7213b9efc59899cb73426ab0568d2117254b1e9900700dab7